Repeated Insult Patch Test of Personal Lubricants
Primary Purpose
Erythema, Edema
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Experimental: Novel lubricant Miami Fragrance
Experimental: Novel lubricant Miami no Fragrance
KY Liquid lubricant
Astroglide Gel lubricant
Sponsored by
About this trial
This is an interventional screening trial for Erythema
Eligibility Criteria
Inclusion Criteria:
- In general good health
- Free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events
- Are of any skin type or race, providing the skin pigmentation will allow discernment of erythema
- Complete a medical screening procedure
- Read, understand, and sign an informed consent agreement
Exclusion Criteria:
- Have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation
- Are receiving systemic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results
- Have psoriasis and/or active atopic dermatitis/eczema.
- Are females who are pregnant, planning on getting pregnant during the study, or breast-feeding
- Have a known sensitivity for cosmetics, skin care products, topical drugs, or any other type of the products, as related to the material being evaluated
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Human Repeat Insult Patch Test
Arm Description
Approximately 0.2ml of each intervention (Experimental: Novel lubricant Miami Fragrance, Experimental: Novel lubricant Miami no Fragrance, KY Liquid lubricant, Astroglide Gel lubricant) was applied to an occlusive patch and applied to participant's back.
Outcomes
Primary Outcome Measures
Number of Participants With Adverse Events as a Measure of Safety and Tolerability
Secondary Outcome Measures
Full Information
NCT ID
NCT02297841
First Posted
November 17, 2014
Last Updated
September 14, 2016
Sponsor
Church & Dwight Company, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT02297841
Brief Title
Repeated Insult Patch Test of Personal Lubricants
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
November 2014 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Church & Dwight Company, Inc.
4. Oversight
5. Study Description
Brief Summary
Determine the ability of the study material (personal lubricant) to cause sensitization by repeated topical application to the skin of humans under controlled patch test conditions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Erythema, Edema
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
209 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Human Repeat Insult Patch Test
Arm Type
Experimental
Arm Description
Approximately 0.2ml of each intervention (Experimental: Novel lubricant Miami Fragrance, Experimental: Novel lubricant Miami no Fragrance, KY Liquid lubricant, Astroglide Gel lubricant) was applied to an occlusive patch and applied to participant's back.
Intervention Type
Device
Intervention Name(s)
Experimental: Novel lubricant Miami Fragrance
Intervention Type
Device
Intervention Name(s)
Experimental: Novel lubricant Miami no Fragrance
Intervention Type
Device
Intervention Name(s)
KY Liquid lubricant
Intervention Type
Device
Intervention Name(s)
Astroglide Gel lubricant
Primary Outcome Measure Information:
Title
Number of Participants With Adverse Events as a Measure of Safety and Tolerability
Time Frame
24, 48, and 72 hours after patch application
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
In general good health
Free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events
Are of any skin type or race, providing the skin pigmentation will allow discernment of erythema
Complete a medical screening procedure
Read, understand, and sign an informed consent agreement
Exclusion Criteria:
Have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation
Are receiving systemic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results
Have psoriasis and/or active atopic dermatitis/eczema.
Are females who are pregnant, planning on getting pregnant during the study, or breast-feeding
Have a known sensitivity for cosmetics, skin care products, topical drugs, or any other type of the products, as related to the material being evaluated
12. IPD Sharing Statement
Learn more about this trial
Repeated Insult Patch Test of Personal Lubricants
We'll reach out to this number within 24 hrs